NumFin

Jiang Zhong Pharmaceutical Co.,Ltd

Sembol: 600750.SS

SHH

27.05

CNY

Bugünkü piyasa fiyatı

  • 23.0341

    F/K Oranı

  • 1.6311

    PEG Oranı

  • 16.91B

    MRK Kapağı

  • 0.05%

    DIV Verimi

Jiang Zhong Pharmaceutical Co.,Ltd (600750-SS) Finansal Tablolar

Download
YıllıkÜç Aylık
DoğrusalGünlük
Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

YıllıkÜç Aylık
10Y20Y30Y40Y

Bilanço

Jiang Zhong Pharmaceutical Co.,Ltd'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

balance-sheet.row.cash-and-short-term-investments

01382.92744.22773.8
2080.9
1581.4
1014.6
724.8
898
250.4
605.5
711.2
957.1
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
117.4
190.2
266.8
240.2
155.2
30.9
59.7
122.4
4.3
2.3
4.9

balance-sheet.row.short-term-investments

0501372.81727.7
980.9
654.1
-1.1
-0.6
-0.6
-0.7
-5
-11.5
-0.9
-1.2
-1.4
0
0
0
0
0
0
0.8
0
0
10
0
0
10
0
0
0
0

balance-sheet.row.net-receivables

0562.8872.5893.1
929.3
1181.2
1005.1
895.4
530.7
789.3
1008.6
700
625.3
669.5
575.1
382.7
536.6
248.3
361.2
172.6
246.1
226.2
141.6
187.6
6.3
3
164.7
110.1
33.6
0
0
0

balance-sheet.row.inventory

0406.2382.2378
246.7
242.5
171.8
194.4
187.5
158.4
312.8
334.9
344.2
293.7
278.6
117.8
100.6
108.7
97.1
87.9
71.9
72.1
81.7
43.6
49.1
71.3
52.7
65.1
71.2
19.7
13.4
9.5

balance-sheet.row.other-current-assets

045.223.219.6
18.3
56.6
102.2
153.4
130.8
170.9
162.7
-7.4
-8.1
-58.6
-69.2
-69.9
-152.7
0.1
0.3
-16.8
0
0.4
0.7
-29.9
185.2
227
-33.5
-15.8
-2.5
0
0
0

balance-sheet.row.total-current-assets

02397.14022.14064.5
3275.2
3061.7
2293.7
1968
1747.2
1368.9
2089.6
1738.7
1918.6
1442.6
1533.5
695.3
615.1
469.8
527.7
327.2
362.4
416.1
414.2
468.2
480.8
456.5
214.8
219.1
224.8
42.9
25.9
24.3

balance-sheet.row.property-plant-equipment-net

01597.515201220.4
1021.6
1062.9
954.5
843.8
722.2
718.6
749.1
798.1
843.7
664.2
504.3
458.2
494.8
579.3
636.4
658.5
630.1
486.3
245
165.1
202.2
195.2
179.8
165.5
91.8
64.7
57.3
51.5

balance-sheet.row.goodwill

041.741.741.7
14.8
14.8
0
0
0
0
0
0
0
0
0
0
0
0
2.3
3
3.8
4.6
5.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0401.1379.1395.5
377.8
360
315.5
325.6
336.3
348.7
374.4
371.3
383.5
403.1
383.7
362.9
381.8
79.7
89.8
98.8
98.5
8.8
4.7
4.4
4.5
2.2
2.8
2.8
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0442.8420.8437.3
392.6
374.8
315.5
325.6
336.3
348.7
374.4
371.3
383.5
403.1
383.7
362.9
381.8
79.7
92.1
101.9
102.3
13.4
10.1
4.4
4.5
2.2
2.8
2.8
0
0
0
0

balance-sheet.row.long-term-investments

0112.9-1197.9-1568.9
-824.3
-435.8
194.1
187.2
204.1
192.6
63.1
68.7
65.8
65.4
67.5
67.9
68.2
0
0
0
0
69.1
0
0
12.8
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

060.444.444.9
39
37
26
27.2
16.4
10.4
11.7
10.4
12.1
10.8
14.6
11.7
25.6
7.5
0
0
0
1.6
0
0
-12.6
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

01517.81434.21799.4
1019.5
658.5
33.2
12.2
39.7
39.1
39.1
5.1
5.1
2.8
2.4
1.6
0.6
85.7
62.3
63.8
69.7
0.6
71.5
1.6
20.8
23.7
23.9
24.6
7.2
0
0
0

balance-sheet.row.total-non-current-assets

03731.42221.61933.1
1648.4
1697.5
1523.2
1396.1
1318.6
1309.4
1237.4
1253.7
1310.3
1146.3
972.5
902.3
971.1
752.1
790.8
824.1
802.1
570.9
326.6
171.1
227.7
221
206.4
192.9
99
64.7
57.3
51.5

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

06128.56243.75997.6
4923.6
4759.2
3817
3364.1
3065.7
2678.3
3327
2992.4
3228.9
2588.8
2506
1597.7
1586.1
1221.9
1318.6
1151.3
1164.6
986.9
740.8
639.3
708.5
677.5
421.3
412
323.8
107.6
83.2
75.8

balance-sheet.row.account-payables

0118.4236.3205.7
45.6
56.3
119.5
88.1
47.7
45.1
308.5
231.9
229.6
249.5
212.6
95.4
46.9
64
119.3
61.6
72.1
65.2
46.5
37.8
34.7
54.4
56.1
43
16.5
8.8
3.8
1.5

balance-sheet.row.short-term-debt

055.621.7
0.1
-112
20
0
30
20
125
25
200
200
225
174
364
274.1
343.1
342.4
270
125.8
59.5
22
18.1
36.3
10
10.8
10
7.2
2
3.1

balance-sheet.row.tax-payables

048.173.948.9
38.4
64.5
86.3
44.7
49.8
20.1
12.1
-55.9
11.8
4
50.4
24.3
32.7
3.2
12
10.5
3.1
31.2
-3.9
1.7
62.5
21.8
-1.2
1
3.1
3
1.7
5.2

balance-sheet.row.long-term-debt-total

011.22.8
0.2
0
50
70
0
0
498.2
496.6
525
0
0
80
0
0
0
0
127.4
36.7
0
0
13
25
53
53
53
49.3
30
30

Deferred Revenue Non Current

048.967.873
50.6
58.1
59.8
48.7
24.3
0.9
12.5
12.7
0
0
0
0
0
0
0
0
0
0
0
0
-13
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

01119.91070.8809.2
386.8
692.6
227.8
241.9
224.1
155.2
125.3
81.3
100.1
119
151
77.8
125.1
18.9
65.3
7.9
10.3
38.7
5.9
3.8
3.2
15
12.8
13.8
24.9
5.1
13.1
9.6

balance-sheet.row.total-non-current-liabilities

018.590.698.6
70.8
85.9
109.8
118.7
24.4
1.1
510.9
509.3
538
12.4
3.5
83.5
2.5
0.2
0.2
0.2
127.6
65.8
26.4
0
14.1
25
53
53
53
49.3
30
30

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

011.22.8
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

01604.51748.31415.1
672.3
834.8
563.5
448.7
450
323.7
1193.9
859.1
1175.8
671.1
726.9
524.7
616.7
383.9
569.9
449.2
501.7
347.1
165.6
88.2
162.7
161.5
143.4
166.5
104.4
70.3
48.9
44.2

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0629.4629.6630
630
525
420
300
300
300
300
311.1
311.1
311.1
311.1
295.9
295.9
295.9
146.1
146.1
146.1
146.1
146.1
146.1
146.1
146.1
124.8
124.8
62.4
27.9
27.9
27.9

balance-sheet.row.retained-earnings

02437.32524.12652.1
2503.9
2339.6
2182.4
1893
1595.3
1335.5
1058.5
883.6
804.7
672.7
559.8
411.8
329.2
252.3
220.3
180.7
153.6
133.6
92.6
61.6
71.8
76.5
52.4
26.7
12.1
0
0
0

balance-sheet.row.accumulated-other-comprehensive-income-loss

0433.4430.1421
371
324.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0331.5307.1300
372
372
650.9
722.2
720.3
718.8
718.8
884.6
884.6
882.7
861.2
318.9
296.1
288.7
380.7
373.2
360.4
322.5
311
315.9
305.3
293.5
100.6
93.9
144.9
9.4
6.4
3.7

balance-sheet.row.total-stockholders-equity

03831.538914003
3876.9
3560.6
3253.3
2915.2
2615.5
2354.3
2077.3
2079.3
2000.4
1866.6
1732.1
1026.6
921.2
836.8
747.1
700
660.1
602.2
549.7
523.6
523.2
516.1
277.9
245.5
219.4
37.3
34.4
31.7

balance-sheet.row.total-liabilities-and-stockholders-equity

06128.56243.75997.6
4923.6
4759.2
3817
3364.1
3065.7
2678.3
3327
2992.4
3228.9
2588.8
2506
1597.7
1586.1
1221.9
1318.6
1151.3
1164.6
986.9
740.8
639.3
708.5
677.5
421.3
412
323.8
107.6
83.2
75.8

balance-sheet.row.minority-interest

0643.6604.4579.5
374.4
363.7
0.1
0.2
0.2
0.2
55.8
53.9
52.6
51.1
47
46.3
48.2
1.1
1.5
2.1
2.8
37.6
25.5
27.5
22.6
0
0
0
0
0
0
0

balance-sheet.row.total-equity

04475.14495.44582.5
4251.3
3924.4
3253.4
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0162.9174.9158.8
156.6
218.3
192.9
186.6
203.4
191.9
58.1
57.2
64.9
64.2
66.1
67.9
68.2
85.7
62.3
63.8
69.3
69.9
70.8
0.1
22.8
23.7
23.8
10
0
0
0
0

balance-sheet.row.total-debt

056.63.24.5
0.3
0
20
70
30
20
623.2
521.6
725
200
225
254
364
274.1
343.1
342.4
397.4
162.5
59.5
22
31.1
61.3
63
63.8
63
56.5
32
33.1

balance-sheet.row.net-debt

0-1276.3-1368.2-1041.6
-1099.7
-927.3
-994.6
-654.8
-868
-230.4
17.7
-189.6
-232.1
-337.9
-523.9
-10.8
233.4
161.5
273.9
258.8
353
45.9
-130.7
-244.8
-199.1
-93.9
32.1
14
-59.4
52.2
29.7
28.2

Nakit Akış Tablosu

Jiang Zhong Pharmaceutical Co.,Ltd'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998

cash-flows.row.net-income

0708.3644.2530.9
490.3
479.4
470.2
417.7
379.8
368
266.8
173.5
226.9
232
261.8
199.2
129.5
96.1
75.7
52.9
43.6
62.8
38.7
47.7
31.7
37.4
33.7

cash-flows.row.depreciation-and-amortization

0122.3121.9115.4
112.8
113
72.5
62.9
65.7
67.8
83.1
93.9
76.2
67.5
70.3
64.8
59.8
60.5
63.1
58.8
42.7
24.6
21.2
15.3
12.4
15
9.5

cash-flows.row.deferred-income-tax

0-13.1-0.7-6.2
-9.6
-0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0-83.110.76.2
9.6
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0161.5312.4330.2
131.7
77.3
-41.3
-353.2
256.8
24.1
-85.8
-161.6
-103.2
-120.6
-127.1
68.6
53.4
-40.1
-121.2
45.4
-96.7
-29.4
32.1
-35.7
80
-96.7
-44.7

cash-flows.row.account-receivables

0291.527.4159.5
240.6
42.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-28.1-4.3-23.6
-6.5
1.9
18.5
-3.4
-24.6
-23.9
-16.6
9.4
-50
-11.2
-164.1
-23.9
7.9
-15.1
-9.4
-20.4
-2.7
0.8
-26.9
5.1
22.8
-17.9
12.3

cash-flows.row.account-payables

0-101.8290200.5
-92.8
33.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

00-0.7-6.2
-9.6
-0.8
-59.8
-349.8
281.4
48
-69.1
-171
-53.1
-109.4
37.1
92.5
45.5
-24.9
-111.8
65.8
-94
-30.2
59
-40.8
57.2
-78.8
-57

cash-flows.row.other-non-cash-items

0182-72.6-59.5
17.8
-28.6
-15.2
-2.4
-4.3
50.8
92.7
6.1
26.5
-10.5
17.3
45.7
26.2
37.2
37.6
41.3
36.7
21
2.9
14
-2.3
22.4
-10

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-208.9-345.6-188.5
-182.5
-76.3
-121.4
-181.2
-70.1
-62.8
-102.3
-64.6
-224.4
-247.5
-140.9
-19.4
-20.5
-11.2
-30.7
-65.4
-263
-231.4
-115.4
-5.1
-27.2
-4.3
-17.5

cash-flows.row.acquisitions-net

0-13.20.11.2
183.2
131.2
0.7
1.1
2.3
14.5
0.1
0
0
0
0
0
-289
0.2
0
0
0.2
0.1
0
14.6
27.3
0
0

cash-flows.row.purchases-of-investments

0-1840.5-3260.4-5196.8
-3459
-2695.4
-13.5
-145
-105
-315.5
-160
0
-1
0
0
0
1.2
-25.9
0
0
-36.2
-0.8
-90.8
-50.1
-60
0
0

cash-flows.row.sales-maturities-of-investments

01880.23685.43949.6
2982.1
2129
72.7
119.9
152.8
215.1
3.3
0
0
0
0
21.2
13.5
0.1
1.3
0.4
0.9
0.4
0
67.2
55.5
0
13.4

cash-flows.row.other-investing-activites

000197.9
-182.5
0.1
0
48
23.4
8.6
-0.2
42.6
0.1
0
0.1
0.2
-3.9
5.6
3.4
9
0.6
1.1
1.2
-5.1
-27.2
3.8
0.1

cash-flows.row.net-cash-used-for-investing-activites

0-182.479.4-1236.6
-658.8
-511.5
-61.5
-157.2
3.4
-140.1
-259
-21.9
-225.4
-247.5
-140.7
2.1
-298.6
-31.2
-26
-56
-297.6
-230.6
-205
21.6
-31.6
-0.4
-4.1

cash-flows.row.debt-repayment

00-30-0.8
0
-70
0
-30
-20
-625
-162.3
-230
-495
-360
-354
-524
-378
-338.9
-267.3
-415
-204.2
-255.5
-132
-18.1
-36.3
-73
-0.8

cash-flows.row.common-stock-issued

002.374.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0-1.1-2.3-73.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-792.7-733.1-313.4
-163.4
-147
-135
-120.9
-123.8
-120.8
-124
-127.4
-109.5
-106.6
-101.7
-136.2
-72.5
-24.1
-44.6
-34.1
-28.6
-20
-15.9
-18.5
-3.5
-4.5
-2.6

cash-flows.row.other-financing-activites

0-9.729.4-36.1
-5.9
-70
0
10
90
20
82.8
25
1019.2
334.8
858.3
414
498.2
284
268.3
345.8
431.9
353.5
158.9
10.3
24.6
224.1
0

cash-flows.row.net-cash-used-provided-by-financing-activities

0-803.6-733.7-349.5
-163.4
-217
-135
-140.9
-53.8
-725.8
-203.4
-332.4
414.7
-131.8
402.6
-246.2
47.7
-79
-43.7
-103.3
199.1
78
11
-26.3
-15.2
146.6
-3.4

cash-flows.row.effect-of-forex-changes-on-cash

0-130.200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

0-38.4361.7-669
-69.7
-87.3
289.8
-173.2
647.7
-355.2
-105.7
-242.5
415.7
-211
484.1
134.2
18
43.5
-14.4
39.1
-72.2
-73.6
-99.1
36.7
74.9
124.3
-18.9

cash-flows.row.cash-at-end-of-period

01332.9550.3188.6
857.6
927.3
1014.6
724.8
898
250.4
605.5
711.2
953.6
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
116.6
190.2
266.8
230.2
155.2
30.9

cash-flows.row.cash-at-beginning-of-period

01371.3188.6857.6
927.3
1014.6
724.8
898
250.4
605.5
711.2
953.6
537.9
748.9
264.8
130.6
112.6
69.1
83.5
44.4
116.6
190.2
289.3
230.2
155.2
30.9
49.8

cash-flows.row.operating-cash-flow

01077.81016917
752.5
641.2
486.2
124.9
698
510.8
356.8
111.9
226.4
168.3
222.3
378.3
268.9
153.6
55.2
198.4
26.3
79
94.9
41.3
121.8
-21.9
-11.4

cash-flows.row.capital-expenditure

0-208.9-345.6-188.5
-182.5
-76.3
-121.4
-181.2
-70.1
-62.8
-102.3
-64.6
-224.4
-247.5
-140.9
-19.4
-20.5
-11.2
-30.7
-65.4
-263
-231.4
-115.4
-5.1
-27.2
-4.3
-17.5

cash-flows.row.free-cash-flow

0868.9670.3728.5
570
564.8
364.9
-56.3
628
448
254.5
47.3
2
-79.3
81.4
359
248.4
142.5
24.5
133
-236.7
-152.4
-20.5
36.2
94.5
-26.2
-28.9

Gelir Tablosu Satırı

Jiang Zhong Pharmaceutical Co.,Ltd'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin 600750.SS brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996199519941993

income-statement-row.row.total-revenue

04327.53811.62874
2441.5
2449.4
1755.2
1746.6
1561.9
2597.4
2834.1
2777.9
3191.8
2647.3
2563.6
1890
1457.6
1168.6
1181.1
979.5
834.5
941.2
667.7
355
368.5
130.1
185
218.6
231.7
338
234.8
213.8

income-statement-row.row.cost-of-revenue

01579.613401024.9
845.5
816.8
571.4
534.4
455
1286.1
1337.7
1730.9
1983.1
1760.4
1437.9
707.3
539.5
402.9
425.8
336.4
345.2
381
284.9
219.2
186.8
97.6
155.6
193.9
204.6
288.3
193.1
165.1

income-statement-row.row.gross-profit

02747.82471.61849.1
1595.9
1632.7
1183.9
1212.2
1106.9
1311.3
1496.4
1047
1208.8
886.9
1125.7
1182.7
918.1
765.7
755.2
643.1
489.2
560.2
382.7
135.7
181.7
32.5
29.4
24.7
27.1
49.7
41.7
48.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0-8.9178.6126.8
100
148.7
-0.2
-10.7
-0.5
9.6
4.7
7.4
1.7
1.6
-7.4
0.6
-6.9
0.6
-8.7
-4.1
0.9
1.1
-2
-7.6
-0.1
48.5
21.3
-0.7
21.5
1.5
0
9.7

income-statement-row.row.operating-expenses

01925.41800.21288.3
1015.3
1110.5
661.7
742.4
670.8
828.9
1083.1
848.6
921.9
629
798
893.4
716.1
606.4
624.8
543.9
408.1
448
309.5
54.2
113.6
24.7
18.2
13.9
12.5
16.8
12.9
22.7

income-statement-row.row.cost-and-expenses

035053140.22313.1
1860.8
1927.3
1233
1276.8
1125.8
2115
2420.8
2579.5
2905
2389.4
2235.9
1600.7
1255.6
1009.2
1050.6
880.2
753.4
829
594.5
273.4
300.4
122.3
173.8
207.8
217.1
16.8
206
22.7

income-statement-row.row.interest-income

067.632.326.3
15.3
17
10.4
10.8
4.5
6.1
6.4
9
8.1
7.4
1.9
1.9
3.7
0
0.7
0.8
0.6
1.1
1.2
1.8
6.5
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

074.43.5
1.9
0.3
0
0.3
4.2
33
38.8
35.9
23
14
13.2
21.1
26.4
11.4
18.8
22.3
15.3
5.8
1.3
2
2.3
0.9
0.8
1
5.6
11.1
8.6
7.3

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

077.64.9-2.8
5.5
-1.6
25.8
2.5
7.5
-42.2
-78.9
11.2
-17.5
18.9
-24.3
-44.4
-35.2
-37.7
-31.6
-18.1
-24.9
-11.2
-4.3
-11.1
7.4
-1
2.5
20.6
15.8
-11.1
-8.6
-7.3

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0-8.9178.6126.8
100
148.7
-0.2
-10.7
-0.5
9.6
4.7
7.4
1.7
1.6
-7.4
0.6
-6.9
0.6
-8.7
-4.1
0.9
1.1
-2
-7.6
-0.1
48.5
21.3
-0.7
21.5
1.5
0
9.7

income-statement-row.row.total-operating-expenses

077.64.9-2.8
5.5
-1.6
25.8
2.5
7.5
-42.2
-78.9
11.2
-17.5
18.9
-24.3
-44.4
-35.2
-37.7
-31.6
-18.1
-24.9
-11.2
-4.3
-11.1
7.4
-1
2.5
20.6
15.8
-11.1
-8.6
-7.3

income-statement-row.row.interest-expense

074.43.5
1.9
0.3
0
0.3
4.2
33
38.8
35.9
23
14
13.2
21.1
26.4
11.4
18.8
22.3
15.3
5.8
1.3
2
2.3
0.9
0.8
1
5.6
11.1
8.6
7.3

income-statement-row.row.depreciation-and-amortization

0122.3107.479
92.2
47.5
72.5
62.9
65.7
67.8
83.1
93.9
76.2
67.5
70.3
64.8
59.8
60.5
63.1
58.8
42.7
24.6
21.2
15.3
12.4
15
9.5
-21.1
5.6
-38.7
8.6
-41.4

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0822.5746.1626
573.9
567.6
548.2
483.1
445.7
430.6
329.9
202.3
267.8
276.9
310.8
245
173.8
121.1
111.9
80.4
59.3
104.2
71.8
77.6
75.6
49.8
36.1
31.9
9
21.9
20.1
18.7

income-statement-row.row.income-before-tax

0900.1751623.1
579.4
566
547.9
472.3
443.6
440.1
334.4
209.5
269.3
276.8
303.4
244.9
166.9
121.7
101
78.7
58.2
103.1
69.3
70.2
75.5
52.5
35.5
31.3
30.5
21.9
20.1
18.7

income-statement-row.row.income-tax-expense

0130.5106.892.2
89.1
86.6
77.7
54.6
63.8
72.1
67.7
36
42.5
44.8
41.6
45.7
37.4
25.6
25.3
25.8
14.6
40.3
30.6
22.5
43.8
15.1
1.9
5.2
4.6
7.2
6.6
-7.3

income-statement-row.row.net-income

0708.3598.2505.7
473.7
463.6
470.2
417.8
379.8
367
264.8
172.3
225.3
227.8
261.2
201.1
130.6
96.6
76.3
53.6
43.1
50.7
43.2
40.2
27.6
37.4
33.7
26.1
25.9
14.7
13.5
18.7
Benzer Hisse Senetleri
Bunlar da ilginizi çekebilir:
CHSYF
China Medical System Holdings Limited.
0.9313 USD
PNK
600479.SS
ZhuZhou QianJin Pharmaceutical Co.,Ltd.
10.92 CNY
SHH
WOCKPHARMA.BO
Wockhardt Limited.
532.5 INR
BSE
185750.KS
Chong Kun Dang Pharmaceutical Corp..
100300 KRW
KSC
ERIS.NS
Eris Lifesciences Limited.
848.1 INR
NSE
300601.SZ
Shenzhen Kangtai Biological Products Co., Ltd..
22.39 CNY
SHZ
TKPHF
Takeda Pharmaceutical Company Limited.
26.83 USD
PNK
MVP.AX
Medical Developments International Limited.
0.61 AUD
ASX
APLLTD.NS
Alembic Pharmaceuticals Limited.
1001.35 INR
NSE
128940.KS
Hanmi Pharm. Co., Ltd..
321500 KRW
KSC
002390.KS
HANDOK Inc..
13700 KRW
KSC

Sıkça Sorulan Sorular

Nedir Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) toplam varlıklar?

Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) toplam varlıklar 6128543353.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir N/A'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.650'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı 1.431'dur.

İşletme net kar marjı nedir?

Net kâr marjı 0.171'dir.

Firma toplam geliri nedir?

Toplam gelir 0.219'dur.

Nedir Jiang Zhong Pharmaceutical Co.,Ltd (600750.SS) net kar (net gelir)?

Net kar (net gelir) 708291520.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 56623813.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 1925353479.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 0.000'tir.